Tag: Defend the NHS

Latest articles

Clovis Oncology's ovarian cancer treatment approved for Cancer Drugs Fund

Clovis Oncology’s ovarian cancer treatment approved for Cancer Drugs Fund

An ovarian cancer treatment, designed to help maintain the effects of chemotherapy, has been approved by NICE for use in the Cancer Drugs Fund...
A wearable sensor is being used to study cancer-related fatigue in patients with breast cancer

Breast cancer-related fatigue to be studied with wearable sensor

A team of researchers from Letterkenny Institute of Technology (LYIT) and Letterkenny University Hospital (LUH) is to use Shimmer’s Verisense™ continuous monitoring platform to...
Science technology equipment: Nick Gabelle is a Multi-Channel Key Account Manager for Star, working with a client on the launch of their new treatment for Type 2 diabetes

Shionogi reports positive results for cefiderocol in adults with pneumonia

Shionogi announce results from APEKS-NP, an international, Phase III clinical trial for cefiderocol in adults with pneumonia.   This trial evaluated the efficacy and safety of...

Popular articles

Man rolling boulder up a hill showing Changes to pharma and healthcare in 2019

Changes to pharma and healthcare in 2019

Continuing funding shortages, Brexit uncertainty, regulator moves and regulation reforms: there is no shortage of change facing the sector in 2019. We asked the industry’s...

Health Secretary Matt Hancock opens Sanofi’s new UK headquarters

Sanofi has officially opened its new UK headquarters at Four 10, Thames Valley Park (TVP) in Reading, Berkshire. Sanofi UK welcomed the Rt Hon Matt...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
Clovis Oncology's ovarian cancer treatment approved for Cancer Drugs Fund

Clovis Oncology’s ovarian cancer treatment approved for Cancer Drugs Fund

An ovarian cancer treatment, designed to help maintain the effects of chemotherapy, has been approved by NICE for use in the Cancer Drugs Fund...
Cancer research to tackle Cancer Research UK is funding three major new international research initiatives on the microbiome, chronic inflammation and why some cancers are specific to certain tissues and not others to tackle global cancer challenges.

Where does the UK market stand in global pharma?

Is pharma entering a new age of innovation and productivity, and where does the UK stand in the global market? The strength of global pharma...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription